Malik and Malik Pharma Private Limited
About Malik and Malik Pharma Private Limited
Data last updated:
Malik and Malik Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 January 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2000PTC228159. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.32 Lakh. It is led by directors Balveer Singh and Rohit Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 36 Ground Floor Shop No. 5, Paradise Shopping Plaza Madhu Vihar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹67,240, a growth of 10% compared to the previous year. For the same year it recorded a net loss of ₹17,140 (net margin -25.5%) and EBITDA of -₹17,140 (EBITDA margin -25.5%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
CIN History
Malik and Malik Pharma has one previous CIN (Corporate Identification Number): U51397HP2000PTC023246. The current CIN is U51397DL2000PTC228159, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51397DL2000PTC228159 | Current |
| U51397HP2000PTC023246 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA – 36 Ground Floor Shop No. 5, Paradise Shopping Plaza Madhu Vihar, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Malik and Malik Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Malik and Malik Pharma Private Limited
FY 2025 filings availableMalik and Malik Pharma Private Limited reported revenue of ₹67,240 (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 44% over three years, including 10% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | -₹17,140 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹17,140 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -25.5% | |
| Net Profit Margin | -25.5% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Malik and Malik Pharma are in the company report.
: available in the company report
Board of Directors of Malik and Malik Pharma Private Limited
Malik and Malik Pharma has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balveer Singh Also directs: Anamya Reality Private Limited, Anamya Buildwell Private Limited, Anantah Buildcon Private Limited and 2 more | Additional Director | 26 Aug 2016 | 10 Years 1 Months | Current |
| Rohit Kumar Also directs: Anamya Reality Private Limited, Anamya Buildwell Private Limited, Anantah Buildcon Private Limited and 2 more | Additional Director | 26 Aug 2016 | 10 Years 1 Months | Current |
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Malik and Malik Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases
Malik and Malik Pharma Private Limited has 1 court case on record: 1 filed by Malik and Malik Pharma. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, CHANDIGARH (UT) | Company petition | Filed by the company against Registrar of Companies, PB., CHD. & HP. | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Malik and Malik Pharma.
: available in the company report
Recent Activity
Malik and Malik Pharma Private Limited has 12 board changes on record since 2009: 2 appointments and 10 cessations. The latest: Hardeep Singh ceased to be Additional Director on 29 Aug 2016.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Malik and Malik Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Malik and Malik Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 January 2000 (26+ years old) and is registered under CIN U51397DL2000PTC228159.
Malik and Malik Pharma has 2 current directors:
- Balveer Singh - Additional Director
- Rohit Kumar - Additional Director
The latest financial statements of Malik and Malik Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Malik and Malik Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Malik and Malik Pharma is U51397DL2000PTC228159. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Malik and Malik Pharma has 1 court case on record: 1 filed by the company.
Malik and Malik Pharma was incorporated on 10 January 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
Hardeep Singh ceased to be Additional Director on 29 Aug 2016. Mam Raj ceased to be Additional Director on 29 Aug 2016. Balveer Singh was appointed as Additional Director on 26 Aug 2016. Malik and Malik Pharma has 12 board changes on record in total.
The registered office of Malik and Malik Pharma is at A – 36 Ground Floor Shop No. 5, Paradise Shopping Plaza Madhu Vihar, New Delhi, Delhi, India – 110092.
Malik and Malik Pharma operates in the pharma industry, in the drug formulation and development segment.